EA202191051A1 - Ингибитор аврора-киназы a для применения для лечения нейробластомы - Google Patents
Ингибитор аврора-киназы a для применения для лечения нейробластомыInfo
- Publication number
- EA202191051A1 EA202191051A1 EA202191051A EA202191051A EA202191051A1 EA 202191051 A1 EA202191051 A1 EA 202191051A1 EA 202191051 A EA202191051 A EA 202191051A EA 202191051 A EA202191051 A EA 202191051A EA 202191051 A1 EA202191051 A1 EA 202191051A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- inhibitor
- aurora kinase
- neuroblastoma
- treatment
- neuroblastoma treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
В изобретении предложен ингибитор аврора-киназы А формулы (I)или его фармацевтически приемлемая соль для применения для лечения нейробластомы.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862773367P | 2018-11-30 | 2018-11-30 | |
PCT/US2019/062718 WO2020112514A1 (en) | 2018-11-30 | 2019-11-22 | An aurora a kinase inhibitor for use in the treatment of neuroblastoma |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202191051A1 true EA202191051A1 (ru) | 2021-08-26 |
Family
ID=68916597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202191051A EA202191051A1 (ru) | 2018-11-30 | 2019-11-22 | Ингибитор аврора-киназы a для применения для лечения нейробластомы |
Country Status (15)
Country | Link |
---|---|
US (1) | US20220000855A1 (ru) |
EP (1) | EP3886855A1 (ru) |
JP (2) | JP2022508183A (ru) |
KR (1) | KR20210084555A (ru) |
CN (1) | CN113038950A (ru) |
AU (1) | AU2019388843B2 (ru) |
BR (1) | BR112021006578A2 (ru) |
CA (1) | CA3121483A1 (ru) |
EA (1) | EA202191051A1 (ru) |
IL (1) | IL282270A (ru) |
MA (1) | MA54290A (ru) |
MX (1) | MX2021006011A (ru) |
SG (1) | SG11202104344RA (ru) |
UA (1) | UA125892C2 (ru) |
WO (1) | WO2020112514A1 (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI785474B (zh) * | 2020-01-22 | 2022-12-01 | 大陸商北京加科思新藥研發有限公司 | 用作選擇性Aurora A抑制劑的新型雜環化合物 |
WO2023005957A1 (en) * | 2021-07-28 | 2023-02-02 | Jacobio Pharmaceuticals Co., Ltd. | Polymorphic forms of aurora a selective inhibitors and uses thereof |
WO2023196887A1 (en) | 2022-04-08 | 2023-10-12 | Eli Lilly And Company | Method of treatment including kras g12c inhibitors and aurora a inhibitors |
WO2024003360A1 (en) | 2022-07-01 | 2024-01-04 | Institut Curie | Biomarkers and uses thereof for the treatment of neuroblastoma |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9576309B2 (en) | 2014-11-12 | 2017-02-21 | Snergy Inc. | Dynamic power sharing system and map view graphical user interface |
TWI693218B (zh) * | 2014-11-14 | 2020-05-11 | 美商美國禮來大藥廠 | 極光a激酶抑制劑 |
-
2019
- 2019-11-22 BR BR112021006578-4A patent/BR112021006578A2/pt unknown
- 2019-11-22 US US17/295,721 patent/US20220000855A1/en active Pending
- 2019-11-22 SG SG11202104344RA patent/SG11202104344RA/en unknown
- 2019-11-22 CN CN201980077760.3A patent/CN113038950A/zh active Pending
- 2019-11-22 AU AU2019388843A patent/AU2019388843B2/en active Active
- 2019-11-22 KR KR1020217015919A patent/KR20210084555A/ko not_active Application Discontinuation
- 2019-11-22 UA UAA202101953A patent/UA125892C2/uk unknown
- 2019-11-22 EP EP19821387.8A patent/EP3886855A1/en not_active Withdrawn
- 2019-11-22 MX MX2021006011A patent/MX2021006011A/es unknown
- 2019-11-22 EA EA202191051A patent/EA202191051A1/ru unknown
- 2019-11-22 JP JP2021529009A patent/JP2022508183A/ja active Pending
- 2019-11-22 CA CA3121483A patent/CA3121483A1/en active Pending
- 2019-11-22 MA MA054290A patent/MA54290A/fr unknown
- 2019-11-22 WO PCT/US2019/062718 patent/WO2020112514A1/en active Application Filing
-
2021
- 2021-04-12 IL IL282270A patent/IL282270A/en unknown
-
2023
- 2023-02-07 JP JP2023016982A patent/JP2023058582A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
BR112021006578A2 (pt) | 2021-07-27 |
MA54290A (fr) | 2022-03-09 |
JP2022508183A (ja) | 2022-01-19 |
AU2019388843A1 (en) | 2021-05-20 |
IL282270A (en) | 2021-05-31 |
EP3886855A1 (en) | 2021-10-06 |
US20220000855A1 (en) | 2022-01-06 |
CN113038950A (zh) | 2021-06-25 |
CA3121483A1 (en) | 2020-06-04 |
MX2021006011A (es) | 2021-09-21 |
AU2019388843B2 (en) | 2023-03-23 |
WO2020112514A1 (en) | 2020-06-04 |
SG11202104344RA (en) | 2021-05-28 |
JP2023058582A (ja) | 2023-04-25 |
UA125892C2 (uk) | 2022-06-29 |
KR20210084555A (ko) | 2021-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201890318A1 (ru) | СОЕДИНЕНИЯ ЗАМЕЩЕННОГО ПИРАЗОЛО[1,5-a]ПИРИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ RET КИНАЗЫ | |
EA201890307A1 (ru) | Индазольные и азаиндазольные соединения как ингибиторы irak-4 | |
CY1119771T1 (el) | Ενωσεις αμινοπυριμιδινυλιου ως αναστολεις toy jak | |
EA202191051A1 (ru) | Ингибитор аврора-киназы a для применения для лечения нейробластомы | |
EA201890308A1 (ru) | Замещенные азасоединения как ингибиторы irak-4 | |
CR20190124A (es) | Inhibidores de ssao de aminopirimidina | |
MD3710446T2 (ro) | Compuși utili pentru inhibarea CDK7 | |
BR112017002594A2 (pt) | compostos inibidores de cinase de ligação de tank | |
EA201991697A1 (ru) | Сульфоксиминовые ингибиторы гликозидазы | |
EA201790271A1 (ru) | Ингибиторы гликозидазы | |
EA201792116A1 (ru) | Ингибитор янус-киназы | |
EA201991884A2 (ru) | Ингибиторы g12c kras | |
EA201692418A1 (ru) | Замещенные индазольные соединения в качестве irak4 ингибиторов | |
UY36153A (es) | ?inhibidores de la fosfoinosítido 3-quinasa delta para su uso en el tratamiento de una enfermedad cutánea inmunoampollosa mediada por autoanticuerpos? | |
EA201791684A1 (ru) | Селективные ингибиторы bace1 | |
EA201992147A1 (ru) | Ингибиторы тирозинкиназы брутона | |
MA52004A (fr) | Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glycopyranosidase | |
AR102981A1 (es) | Inhibidores de la necrosis celular y métodos de preparación de los mismos | |
EA202193015A1 (ru) | Ингибиторы cdk | |
EA201992320A1 (ru) | Пиперидины в качестве ковалентных ингибиторов менина | |
CY1121334T1 (el) | Αναστολεας κινασης aurora a | |
EA201691600A1 (ru) | Дигидропиридиноновые ингибиторы mgat2 для применения в лечении метаболических нарушений | |
EA201692470A1 (ru) | Фармацевтические комбинации | |
UY38233A (es) | Agentes inhibidores para la tirosina cinasa de bruton | |
CL2021000580A1 (es) | Uso de inhibidores de la caseina quinasa 1 para el tratamiento de enfermedades vasculares. |